{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:11:08Z","timestamp":1776251468610,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Advantageous Discipline Group Project of Ningxia Medical University General Hospital","award":["YSXKQ2024002"],"award-info":[{"award-number":["YSXKQ2024002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-04111-7","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:22:57Z","timestamp":1772932977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features, prognosis, and influencing factors of relapse in autoimmune encephalitis associated with antibodies against cell surface antigens: a single-center retrospective study"],"prefix":"10.1186","volume":"31","author":[{"given":"Pankui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"key":"4111_CR1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340. https:\/\/doi.org\/10.1136\/jnnp.2003.034447.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4111_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103118","volume":"21","author":"N Seery","year":"2022","unstructured":"Seery N, Butzkueven H, O\u2019Brien TJ, Monif M. Rare antibody-mediated and seronegative autoimmune encephalitis: an update. Autoimmun Rev. 2022;21:103118. https:\/\/doi.org\/10.1016\/j.autrev.2022.103118.","journal-title":"Autoimmun Rev"},{"key":"4111_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25\u201336. https:\/\/doi.org\/10.1002\/ana.21050.","journal-title":"Ann Neurol"},{"key":"4111_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.25421","volume":"85","author":"JA Lim","year":"2019","unstructured":"Lim JA, Lee ST, Moon J, Jun JS, Kim TJ, Shin YW, et al. Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol. 2019;85:352\u20138. https:\/\/doi.org\/10.1002\/ana.25421.","journal-title":"Ann Neurol"},{"key":"4111_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"key":"4111_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.791014","volume":"12","author":"Y Teng","year":"2021","unstructured":"Teng Y, Li T, Yang Z, Su M, Ni J, Wei M, et al. Clinical features and therapeutic effects of anti-leucine-rich glioma inactivated 1 encephalitis: a systematic review. Front Neurol. 2021;12:791014. https:\/\/doi.org\/10.3389\/fneur.2021.791014.","journal-title":"Front Neurol"},{"key":"4111_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3988\/jcn.2014.10.2.157","volume":"10","author":"JA Lim","year":"2014","unstructured":"Lim JA, Lee ST, Jung KH, Kim S, Shin JW, Moon J, et al. Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome. J Clin Neurol. 2014;10:157\u201361. https:\/\/doi.org\/10.3988\/jcn.2014.10.2.157.","journal-title":"J Clin Neurol"},{"key":"4111_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41598-018-19490-z","volume":"8","author":"Y Jang","year":"2018","unstructured":"Jang Y, Lee ST, Kim TJ, Jun JS, Moon J, Jung KH, et al. High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis. Sci Rep. 2018;8:1012. https:\/\/doi.org\/10.1038\/s41598-018-19490-z.","journal-title":"Sci Rep"},{"key":"4111_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF02035107","volume":"11","author":"MA Foster","year":"1986","unstructured":"Foster MA, Kilcoyne RF. Ruvalcaba-Myhre-Smith syndrome: a new consideration in the differential diagnosis of intestinal polyposis. Gastrointest Radiol. 1986;11:349\u201350. https:\/\/doi.org\/10.1007\/BF02035107.","journal-title":"Gastrointest Radiol"},{"key":"4111_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020506","author":"S Bergeret","year":"2023","unstructured":"Bergeret S, Birzu C, Meneret P, Giron A, Demeret S, Marois C, et al. Brain metabolic alterations in seropositive autoimmune encephalitis: an (18)F-FDG PET study. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11020506.","journal-title":"Biomedicines"},{"key":"4111_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","volume":"13","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol. 2017;13:290\u2013301. https:\/\/doi.org\/10.1038\/nrneurol.2017.43.","journal-title":"Nat Rev Neurol"},{"key":"4111_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1793","volume":"10","author":"P Ghimire","year":"2020","unstructured":"Ghimire P, Khanal UP, Gajurel BP, Karn R, Rajbhandari R, Paudel S, et al. Anti-LGI1, anti-GABABR, and anti-CASPR2 encephalitides in Asia: a systematic review. Brain Behav. 2020;10:e01793. https:\/\/doi.org\/10.1002\/brb3.1793.","journal-title":"Brain Behav"},{"key":"4111_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0721-y","volume":"20","author":"RS Grativvol","year":"2018","unstructured":"Grativvol RS, Cavalcante WCP, Castro LHM, Nitrini R, Simabukuro MM. Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes. Curr Oncol Rep. 2018;20:92. https:\/\/doi.org\/10.1007\/s11912-018-0721-y.","journal-title":"Curr Oncol Rep"},{"key":"4111_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0693-7","volume":"7","author":"A Chefdeville","year":"2019","unstructured":"Chefdeville A, Treilleux I, Mayeur ME, Couillault C, Picard G, Bost C, et al. Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis. Acta Neuropathol Commun. 2019;7:38. https:\/\/doi.org\/10.1186\/s40478-019-0693-7.","journal-title":"Acta Neuropathol Commun"},{"key":"4111_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955170","volume":"13","author":"S Gong","year":"2022","unstructured":"Gong S, Han Y, He E, Liu M, Fu X, Deng F. Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: a case report. Front Immunol. 2022;13:955170. https:\/\/doi.org\/10.3389\/fimmu.2022.955170.","journal-title":"Front Immunol"},{"key":"4111_CR16","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/brain\/awz094","volume":"142","author":"MH van Coevorden-Hameete","year":"2019","unstructured":"van Coevorden-Hameete MH, de Bruijn M, de Graaff E, Bastiaansen D, Schreurs MWJ, Demmers JAA, et al. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies. Brain. 2019;142:1631\u201343. https:\/\/doi.org\/10.1093\/brain\/awz094.","journal-title":"Brain"},{"key":"4111_CR17","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","volume":"86","author":"M Dogan Onugoren","year":"2015","unstructured":"Dogan Onugoren M, Deuretzbacher D, Haensch CA, Hagedorn HJ, Halve S, Isenmann S, et al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry. 2015;86:965\u201372. https:\/\/doi.org\/10.1136\/jnnp-2014-308814.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4111_CR18","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain. 2010;133:2734\u201348. https:\/\/doi.org\/10.1093\/brain\/awq213.","journal-title":"Brain"},{"key":"4111_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1585-y","volume":"20","author":"X Zhang","year":"2020","unstructured":"Zhang X, Lang Y, Sun L, Zhang W, Lin W, Cui L. Clinical characteristics and prognostic analysis of anti-gamma-aminobutyric acid-B (GABA-B) receptor encephalitis in Northeast China. BMC Neurol. 2020;20:1. https:\/\/doi.org\/10.1186\/s12883-019-1585-y.","journal-title":"BMC Neurol"},{"key":"4111_CR20","first-page":"18927","volume":"8","author":"X Huang","year":"2015","unstructured":"Huang X, Fan C, Wu J, Ye J, Zhan S, Song H, et al. Clinical analysis on anti-N-methyl-D-aspartate receptor encephalitis cases: Chinese experience. Int J Clin Exp Med. 2015;8:18927\u201335.","journal-title":"Int J Clin Exp Med"},{"key":"4111_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s13311-020-00921-7","volume":"18","author":"WJ Lee","year":"2021","unstructured":"Lee WJ, Lee ST, Shin YW, Lee HS, Shin HR, Kim DY, et al. Teratoma removal, steroid, IVIG, rituximab and tocilizumab (T-SIRT) in anti-NMDAR encephalitis. Neurotherapeutics. 2021;18:474\u201387. https:\/\/doi.org\/10.1007\/s13311-020-00921-7.","journal-title":"Neurotherapeutics"},{"key":"4111_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577527","volume":"354","author":"T Wang","year":"2021","unstructured":"Wang T, Wang B, Zeng Z, Li H, Zhang F, Ruan X, et al. Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: an observational study. J Neuroimmunol. 2021;354:577527. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577527.","journal-title":"J Neuroimmunol"},{"key":"4111_CR23","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/WCO.0000000000000391","volume":"29","author":"AF Hottinger","year":"2016","unstructured":"Hottinger AF. Neurologic complications of immune checkpoint inhibitors. Curr Opin Neurol. 2016;29:806\u201312. https:\/\/doi.org\/10.1097\/WCO.0000000000000391.","journal-title":"Curr Opin Neurol"},{"key":"4111_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/neuonc\/nou030","volume":"16","author":"J Dalmau","year":"2014","unstructured":"Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro Oncol. 2014;16:771\u20138. https:\/\/doi.org\/10.1093\/neuonc\/nou030.","journal-title":"Neuro Oncol"},{"key":"4111_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1284717","volume":"14","author":"S Ogami","year":"2023","unstructured":"Ogami S, Koh J, Miyamoto K, Mori M, Takahashi M, Nakayama Y, et al. Predictive value of the neutrophil-to-lymphocyte ratio for treatment response in patients diagnosed with definite or probable autoimmune encephalitis\/encephalopathy. Front Neurol. 2023;14:1284717. https:\/\/doi.org\/10.3389\/fneur.2023.1284717.","journal-title":"Front Neurol"},{"key":"4111_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.861988","volume":"13","author":"F Liu","year":"2022","unstructured":"Liu F, Zhang B, Huang T, Wang B, Wang C, Hao M, et al. Influential factors, treatment and prognosis of autoimmune encephalitis patients with poor response to short-term first-line treatment. Front Neurol. 2022;13:861988. https:\/\/doi.org\/10.3389\/fneur.2022.861988.","journal-title":"Front Neurol"},{"key":"4111_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.911779","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li Y, Wang Y, Zhang H, Lian Y, Cheng X. The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with the severity of autoimmune encephalitis. Front Immunol. 2022;13:911779. https:\/\/doi.org\/10.3389\/fimmu.2022.911779.","journal-title":"Front Immunol"},{"key":"4111_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9.","journal-title":"Lancet Neurol"},{"key":"4111_CR29","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000958","author":"X Gong","year":"2021","unstructured":"Gong X, Chen C, Liu X, Lin J, Li A, Guo K, et al. Long-term functional outcomes and relapse of anti-NMDA receptor encephalitis: a cohort study in Western China. Neurol Neuroimmunol Neuroinflamm. 2021. https:\/\/doi.org\/10.1212\/NXI.0000000000000958.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4111_CR30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4149\/BLL_2021_078","volume":"122","author":"R Zahorec","year":"2021","unstructured":"Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122:474\u201388. https:\/\/doi.org\/10.4149\/BLL_2021_078.","journal-title":"Bratisl Lek Listy"},{"key":"4111_CR31","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.3748\/wjg.v22.i21.5088","volume":"22","author":"HJ Yang","year":"2016","unstructured":"Yang HJ, Guo Z, Yang YT, Jiang JH, Qi YP, Li JJ, et al. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: a propensity score-based analysis. World J Gastroenterol. 2016;22:5088\u201395. https:\/\/doi.org\/10.3748\/wjg.v22.i21.5088.","journal-title":"World J Gastroenterol"},{"key":"4111_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.597858","volume":"11","author":"J Broadley","year":"2020","unstructured":"Broadley J, Wesselingh R, Seneviratne U, Kyndt C, Beech P, Buzzard K, et al. Peripheral immune cell ratios and clinical outcomes in seropositive autoimmune encephalitis: a study by the Australian Autoimmune Encephalitis Consortium. Front Immunol. 2020;11:597858. https:\/\/doi.org\/10.3389\/fimmu.2020.597858.","journal-title":"Front Immunol"},{"key":"4111_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.827138","volume":"13","author":"Y Luo","year":"2022","unstructured":"Luo Y, Li J, Jiang F, Tan A, Qin X, Xiao X, et al. Autoimmune encephalitis with psychotic manifestations and cognitive impairment presenting as schizophrenia: case report and literature review. Front Psychiatry. 2022;13:827138. https:\/\/doi.org\/10.3389\/fpsyt.2022.827138.","journal-title":"Front Psychiatry"},{"key":"4111_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jocn.2024.04.021","volume":"124","author":"S Sai Folmsbee","year":"2024","unstructured":"Sai Folmsbee S, Hui G, Yuan Y, Gombar S, Han M, Le S. Antipsychotic medications associated with increased length of hospital stay in autoimmune encephalitis and multiple sclerosis: a retrospective study. J Clin Neurosci. 2024;124:87\u201393. https:\/\/doi.org\/10.1016\/j.jocn.2024.04.021.","journal-title":"J Clin Neurosci"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-04111-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:29:39Z","timestamp":1776248979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-04111-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4111"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-04111-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Ningxia Medical University (Nr. KYLL-2024-1609). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"555"}}